Disrupting Big Pharma | Lou Reese & Marc Beckman

Disrupting Big Pharma | Lou Reese & Marc Beckman

From Some Future Day by Marc Beckman

July 8, 2025 · 57 min

About this episode

Lou Reese discusses a new model for drug development that prioritizes patients over profit in the pharmaceutical industry.

”For the first time in history - less than a decade ago - chronic diseases started killing us more than famine, pestilence, bacteria, viruses, all those things combined.” Yet, despite the suffering of millions, innovation is being strangled by a broken pharmaceutical system where red tape, corporate greed, and bureaucratic middlemen leave patients behind. But what if there's another way? My guest, biotech entrepreneur and humanitarian Lou Reese, believes there is. And he's not just dreaming. Lou is building it. In this conversation, Lou reveals a radical new model for drug development and delivery, one that bypasses Big Pharma, puts patients first, and could bring breakthrough treatments to market faster and at a fraction of the cost. Together, we unpack how Parkinson's patients, just like those with Alzheimer's, are being failed by a system that prioritizes profit over access. And we explore how a bold America First Pharma plan might change that forever. This is a call to action! Because if we don't fight for innovation now, we'll be trapped in the same failing system tomorrow. This is Some Future Day. And that future starts now. Episode Links: Lou on X…

People in this episode

Host: Marc Beckman

Guest: Lou Reese

Topics covered

  • pharmaceutical innovation
  • chronic diseases
  • drug development
  • patient access
  • biotech
  • healthcare reform

Keywords

  • Big Pharma
  • drug development
  • chronic diseases
  • patient access
  • biotech
  • healthcare reform

Mentioned in this episode

Organizations: Big Pharma

Books & works: Some Future Day: How AI Is Going to Change Everything

More episodes of Some Future Day

Explore listener stats, chart rankings, contacts and more on the Some Future Day podcast page.